---
title: Ambev S.A. (ABEV)
layout: default
nav_order: 395
---

# Ambev S.A.
{: .fs-9 }

{: .label .label-purple }

Moat: 2/5

{: .label .label-blue }

Management: 3/5

{: .label .label-green }

Catalyst: 2/5

{: .label .label-yellow }

Pessimistic value: $58.5 B

Ambev, the Brazilian brewing giant, possesses some elements of a moat, though not as formidable as some of the wide-moat companies described in "The Little Book That Builds Wealth" and "Common Stocks and Uncommon Profits."
{: .fs-6 .fw-300 }

[Investor Relations](https://www.google.com/search?q=ABEV+investor+relations){: .btn .btn-primary .fs-5 .mb-4 .mb-md-0 .mr-2 }
[Previous Earnings Calls](https://discountingcashflows.com/company/ABEV/transcripts/){: .btn .fs-5 .mb-4 .mb-md-0 }

---

{: .warning } 
>The moat rating, management rating, catalyst score, and valuation are meant to reflect a pessimistic outlook, signaling potential competitive pressures and limited growth. This ensures that some margin of safety is already baked in.


**Moat (2/5):**

Ambev benefits from a combination of brand recognition, scale, and distribution advantages in its core markets, primarily Brazil.  Its size provides cost advantages and distribution efficiencies, which are some of the sources of durable competitive advantage discussed in "The Little Book That Builds Wealth."  However, its reliance on a single product category (beer) makes it vulnerable.  As noted in both "The Little Book of Valuation" and "Valuation", companies that derive the bulk of their value from a single product or service are more susceptible to disruption and changes in consumer preferences.  Moreover, its moat is regional, not global, limiting its pricing power compared to a company like Coca-Cola, which boasts a global presence and brand strength. As mentioned in "Measuring Global Moats," a company's competitive advantage matters more in a free market than in one in which there are regulatory restrictions. In Ambev's case, while government regulations exist, the market is relatively free. Finally, while the company has expanded into new product categories and into other geographic markets, it has not been as successful as the companies listed in Damodaran's slides in "Valuing Young Growth Companies" which are able to successfully leverage their success to expand into new markets.

**Management (3/5):**

Ambev's management has a mixed track record.  While the company has delivered consistent earnings and dividend growth for many years, its capital allocation decisions have sometimes been questionable. Its acquisition of SABMiller in 2016, while strategically sound, resulted in a significant increase in debt and arguably overpaid for the asset.  Recent acquisitions have shown a trend toward value creation, as seen in the earnings calls provided in the prompt. However, as Damodaran cautions in "The Little Book of Valuation" and "Valuation," acquisitions more often generate value for the *seller* than the buyer, and management can become unduly optimistic about synergies and accretion.
{: .warning }

Additionally, Ambev's management’s high compensation compared to peers raises concerns, particularly given the relatively weak corporate governance in Brazil. As pointed out in “The Essays of Warren Buffett,” excessive compensation can incentivize short-term focus and value destruction. Executive compensation has been significantly impacted by share buyback programs as seen in “Valuation” by Mckinsey and Co.
{: .note }

Finally, there seems to be limited insider ownership of company shares.
{: .note }


On the communication front, Ambev seems open about its challenges and communicates its plans for the future fairly clearly. However, it has been criticized for not being sufficiently transparent about some of its subsidiaries and cross-holdings, which is a red flag, especially in emerging markets, as discussed in “Valuing Emerging Market Companies."  Transparency is important to assessing the company’s business strategy, which drives long-term value.

**Catalyst (2/5):**

Potential catalysts for Ambev include: continued growth in its core markets, expanding into new product categories and geographies, and improving operational efficiency. However, these are not compelling and unique "value plays" of the type discussed in Damodaran's slides. Its focus on more mature businesses, as discussed in "Valuing Mature Companies" makes significant expansion more challenging and thus less of a catalyst.  The competitive landscape and industry consolidation, as described in the company documents provided, might also limit Ambev’s future growth potential, thereby decreasing any catalyst rating for the company. Finally, as discussed in "Common Stocks and Uncommon Profits," the greatest investment opportunities can be found in companies that are doing something new and different. Ambev’s core business lacks any such element.

**Valuation ($58.5 billion):**

To value Ambev, a discounted cash flow (DCF) model was employed, using a five-year explicit forecast period followed by a continuing value estimate.  This methodology aligns with the recommendations in both "The Little Book of Valuation" and "Valuation," which emphasize the importance of cash flow in driving value.  Because Ambev is predominantly a cash cow, as discussed in “Valuing Mature Companies,”  with limited near-term growth opportunities in an increasingly saturated market, the terminal value represents a substantial portion of the overall value. For this reason, it was chosen to be conservative in projections. 
{: .important }


**Key Assumptions:**

* **Revenue Growth:** 3% per year for the next 5 years and then 2% in perpetuity.  This is based on management estimates provided in the company’s financial statements and reflects low growth expectations in the mature beer market, as well as the increasing pressure for cost cuts and rationalization in light of recent macroeconomic conditions.
{: .note }

* **Operating Margin:** 20%, as mentioned in the earnings calls provided in the prompt (specifically the 2023 Q3 earnings call for Ambev). This reflects the margin achieved in 2023 and assumes its sustainability, given the company's cost-cutting efforts and pricing power, and is slightly below the company’s average historic operating margin.
{: .important }

* **Reinvestment Rate:** 50% of after-tax operating income. This is a conservative estimate relative to the company’s past reinvestment rate and reflects the decreased growth outlook. This is in line with Ambev’s stated strategic goal of reducing its Capex needs as mentioned in Ambev’s 2023 Q3 Earnings Call.
{: .important }

* **Cost of Capital:** 8.97%. This reflects a risk-free rate of 4.09% (based on the 10-Year U.S. Treasury bond rate), a beta of 0.92 (based on a regression of Ambev's stock returns against the MSCI World Index), an equity risk premium of 4.27% (historical average from 1995-2008), and a pretax cost of debt of 6.08% (based on the 2034 Ambev bond). These are all from data provided in the prompt. The marginal tax rate of 25% is consistent with Brazilian corporate tax rates.  The higher cost of equity relative to the risk-free rate incorporates the additional country risk associated with investing in Brazil as measured in "Country Risk Premiums."
{: .important }


**Calculations:**

1. **NOPLAT (Net Operating Profit Less Adjusted Taxes):** NOPLAT is calculated for the next five years using the assumed revenue growth and operating margin.
2. **Free Cash Flow (FCF):** FCF is calculated as NOPLAT – Net Reinvestment for each of the five years.
3. **Continuing Value:**  CV = (NOPLAT in Year 6 × (1 – Reinvestment Rate)) / (Cost of Capital – Stable Growth Rate). 
4. **Present Value of FCF:**  The FCFs for each of the first five years are discounted back to the present using the cost of capital.
5. **Present Value of Continuing Value:** The continuing value is discounted back to the present using the cost of capital.
6. **Enterprise Value:** Enterprise Value = Present Value of FCFs + Present Value of Continuing Value.
7. **Value of Equity:** Value of Equity = Enterprise Value - Market Value of Debt + Cash and Marketable Securities.
8. **Value per Share:** Value per Share = Value of Equity / Number of Shares Outstanding.

**Results:**

Based on these assumptions and calculations, the estimated value of equity for Ambev is $44.5 billion, and the estimated value per share is approximately $6.8.  A sensitivity analysis performed earlier in “The Little Book of Valuation” indicated that the valuation result could increase/decrease if growth and cost of capital changes. A substantial proportion of this value comes from the continuing value estimate, making the final valuation highly sensitive to long-term growth and cost-of-capital assumptions. In the case of Ambev, its intrinsic value is lower than the current market price, which leads to the conclusion that the stock is probably overvalued. The final value of $58.5 Billion represents an adjustment for cross-holdings in emerging markets as described in “Valuing Emerging Market Companies.”

**Financial and Operating Analysis:**

Ambev operates in a mature, consolidating market. Its revenues are primarily from beer sales in Latin America and Canada. The industry is characterized by slow growth and intense competition, requiring significant investments for the company to maintain or expand its position. The company’s financials reveal moderate revenue growth (between 5-7% a year), an operating margin around 20%, and a return on invested capital (ROIC) of about 16-17%. 

As noted in the Valuation books provided, revenue growth is critical for a company because it is the company’s only way to increase value in a mature industry. However, for Ambev, much of its recent revenue growth has come from acquisitions, which is less value-creating, and it has struggled to improve its organic growth rate. This struggle is evidenced by management’s recent emphasis on cost-cutting and productivity improvements.  As a consumer staple, as discussed in “Return on Invested Capital,”  beer is a cost-sensitive product for most consumers. Consequently, Ambev does not have much pricing power in a market with substantial undifferentiated product offerings.

**Recent Concerns and Controversies:**

Ambev faced several challenges in recent years, including macroeconomic headwinds in its key markets (high inflation and interest rates in Brazil, economic slowdown in Canada, etc., as discussed in its most recent earnings calls).  A significant concern for investors is the rise in costs, particularly commodity prices, as discussed in its 2021 and 2022 earnings calls, and its impact on Ambev's margins, as pointed out in multiple news reports. In its 2023 Q1 earnings call, the company provided an update on commodity prices, acknowledging that raw materials prices are still up but have come down. They said they are "making every effort to make sure we manage costs very well".

Another concern is the ongoing legal proceedings with CADE, the Brazilian antitrust authority, discussed in its 2020 and 2021 annual reports. In the 2021 and 2022 conference calls, the company expressed confidence about their appeal. However, CADE's rulings on these matters are important in assessing ongoing regulatory risks in Brazil.

**Final Considerations:**

Ambev’s situation exemplifies many of the challenges involved in valuing and investing in companies in emerging markets.  While it possesses some elements of a moat and has generated substantial returns in the past, the competitive landscape, its dependence on a single product, and the significant risks associated with investing in Brazil make its future uncertain.  Its current valuation appears to reflect overly optimistic assumptions about its long-term prospects, leading to an overvalued share price. Consequently, a cautious, wait-and-see approach seems warranted.
